UC

Clinical trials for UC explained in plain language.

Never miss a new study

Get alerted when new UC trials appear

Sign up with your email to follow new studies for UC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could CAR-T cells tame severe colitis? early trial launches

Disease control Recruiting now

This early-phase trial tests whether a patient's own immune cells, engineered to target BCMA and/or CD19, can calm severe ulcerative colitis that hasn't responded to other treatments. Twelve adults with moderate-to-severe active disease will receive a single infusion of these CAR…

Matched conditions: UC

Phase: EARLY_PHASE1 • Sponsor: Hebei Senlang Biotechnology Inc., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 09:08 UTC

UC

Get alerted when new UC trials appear

Could CAR-T cells tame severe colitis? early trial launches